W. L. Gore & Associates, Inc. Product Pipeline Analysis

Publication Date	May 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	46
ISBN Number	not applicable
Product Code	GMD04715

Price

£425.00
approximately: $750 | €539

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a W. L. Gore & Associates, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reason to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook - Cardiovascular Devices
- 2.5 Industry Outlook - Orthopedic Devices
3 W. L. Gore & Associates, Inc. Pipeline Products
- 3.1 W. L. Gore & Associates, Inc. Product Pipeline Analysis
  - 3.1.1 W. L. Gore & Associates, Inc. Pipeline Products By Equipment Type
  - 3.1.2 W. L. Gore & Associates, Inc. Pipeline Products By Development Stage
  - 3.1.3 W. L. Gore & Associates, Inc. Pipeline Products By Therapy Area
  - 3.1.4 W. L. Gore & Associates, Inc. Pipeline Products By Clinical Trials
  - 3.1.5 W. L. Gore & Associates, Inc. Pipeline Products By News Summary
- 3.2 45 mm GORE TAG
  - 3.2.1 Product Description
  - 3.2.2 Product Institution Details
  - 3.2.3 Product Status
  - 3.2.4 Clinical Trials
  - 3.2.5 Product Milestone
- 3.3 GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface
  - 3.3.1 Product Description
  - 3.3.2 Product Status
  - 3.3.3 Clinical Trials
  - 3.3.4 Product Milestone
  - 3.3.5 Product Patent Details
- 3.4 GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface
  - 3.4.1 Product Description
  - 3.4.2 Product Status
  - 3.4.3 Clinical Trials
  - 3.4.4 Product Milestone
4 Business Description
- 4.1 Business Overview
- 4.2 Major Products and Services
  - 4.2.1 Overview
5 History
6 Competitors
7 Key Employees
8 Company Statement
9 Locations And Subsidiaries
- 9.1 Head Office
- 9.2 Other Locations & Subsidiaries
10 Financial Deals Landscape
- 10.1 Acquisition
  - 10.1.1 W. L. Gore & Associates Acquires Amesil
  - 10.1.2 W. L. Gore & Associates Acquires Neural Intervention Technologies
  - 10.1.3 W. L. Gore & Associates Acquires Carmeda
  - 10.1.4 W. L. Gore & Associates Acquires Tetrad
  - 10.1.5 W. L. Gore & Associates Acquire ArteriA Medical Science
- 10.2 Partnership
  - 10.2.1 CONMED Signs An Agreement With W.L. Gore & Associates
  - 10.2.2 W. L. Gore & Associates Signs An Agreement With Datascope
  - 10.2.3 W. L. Gore & Associates Signs Distribution Agreement With Intermagnetics General
11 Recent Developments
- 11.1 Strategy and Business Planning
  - 11.1.1 Sep 27, 2007: W.L. Gore Announces Strategic Alliance With Quellan
- 11.2 Product Announcements
  - 11.2.1 May 06, 2008 Gore Receives CE Mark For GORE PRECLUDE Vessel Guard
  - 11.2.2 May 05, 2008 Gore Receives Approval From FDA For Unique Patent Foramen Ovale Stroke Study
  - 11.2.3 Apr 29, 2008 GORE-TEX Suture Now Designed For Use With CAPIO Suture Capturing Devices
  - 11.2.4 Apr 09, 2008 Gore Changes Landscape In Soft Tissue Repair With GORE BIO-A Tissue Reinforcement
  - 11.2.5 Apr 08, 2008 Gore REVISE Study Receives Approval From FDA
  - 11.2.6 Mar 28, 2008 Gore Announces First Patient Enrolled In PRODIGY Study
  - 11.2.7 Feb 25, 2008 First Patient Enrolled In Study Evaluating Performance Of Spectranetics Laser Ablation Followed By GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface
  - 11.2.8 Jan 02, 2008 VIBRANT Study Of GORE VIABAHN Endoprosthesis Completes Enrollment
  - 11.2.9 Dec 11, 2007 W. L. Gore & Associates Announces Summary Of GORE PROPATEN Vascular Graft Study Data
  - 11.2.10 Nov 12, 2007 Endovascular Repair Of An Abdominal Aortic Aneurysm With The GORE EXCLUDER AAA Endoprosthesis
  - 11.2.11 Oct 26, 2007 W. L. Gore & Associates Announces Endovascular Repair Using GORE EXCLUDER AAA Endoprosthesis
  - 11.2.12 Feb 20, 2007 W. L. Gore & Associates Enrolls First Patient In Study Of 45mm GORE TAG Thoracic Endoprosthesis
  - 11.2.13 Oct 17, 2005 First Patient Treated in VIBRANT Study of GORE VIABAHN Endoprosthesis vs. Bare Nitinol Stent to Treat Lower Limb Vascular Disease
  - 11.2.14 Jun 14, 2005 Gore Receives FDA Approval for GORE VIABAHN Endoprosthesis
  - 11.2.15 Dec 12, 2007: Bard Announces Patent Infringement Verdict Against W. L. Gore
12 Appendix
- 12.1 Methodology
  - 12.1.1 Coverage
  - 12.1.2 Secondary Research
  - 12.1.3 Primary Research
  - 12.1.4 Expert Panel Validation
- 12.2 Contact Us
- 12.3 About Global Markets Direct
- 12.4 Disclaimer
List of Tables
- Table 1: W. L. Gore & Associates, Inc.,Key Facts
- Table 2: W. L. Gore & Associates, Inc. Pipeline Products by Equipment Type
- Table 3: W. L. Gore & Associates, Inc. Pipeline Products By Development Stage
- Table 4: W. L. Gore & Associates, Inc. Pipeline Products By Therapy Area
- Table 5: W. L. Gore & Associates, Inc. Pipeline Products By Clinical Trials
- Table 6: W. L. Gore & Associates, Inc. Pipeline Products By News Summaries
- Table 7: W. L. Gore & Associates, Inc., Key Employees,
- Table 8: W. L. Gore & Associates, Inc., Other Locations
- Table 9: W. L. Gore & Associates, Inc., Subsidiaries
List of Figures
- Figure 1: Global Markets Direct Methodology